Cytotoxicity of Ethanolic Extracts of Artemisia annua to Molt-4 Human Leukemia Cells

Abstract

Although dihydroartemisinin (DHA) and other artemisinin derivatives have selective toxicity towards cancer cells, Artemisia annua (A. annua) extracts containing artemisinin have not been evaluated for their anticancer potential. Our main goal was to assess the anticancer effect of ethanolic leaf extracts of A. annua from Brazilian and Chinese origins (with DHA as a comparison) on normal and cancer cells. Leukocytes and leukemia (Molt-4) cells were counted at 0, 24, 48, and 72 hr after treatment with extracts having artemisinin concentrations of 0, 3.48, 6.96, and 13.92 µg/mL. Also, we assessed the antioxidant capacity of these extracts using the oxygen radical absorbance capacity (ORAC) test. Both extracts had high antioxidant capacity and toxicity towards Molt-4 cells. DHA was significantly more potent (p < 0.05) in killing Molt-4 cells than Brazilian extract at 48 and 72 hr and Chinese extract at 72 hr. In Molt-4 cells, LD₅₀ values for Brazilian and Chinese extracts were comparable at all time points and not significantly different from DHA at 24 hr. In leukocytes, DHA, Chinese extract, and Brazilian extract had LD₅₀ values of 760.42, 13.79, and 28.23 µg/mL of artemisinin, respectively, indicating a better safety index for the Brazilian extract compared to that of the Chinese extract at 24 hr. However, at 48 and 72 hr, the toxicity in leukocytes for any of the treatment groups was not significantly different. These experiments suggest that these extracts may have potential application in cancer treatment.

Key words

Artemisia annua - Asteraceae - ethanolic extracts - antioxidant - flavonoids - synergism - leukemia - MOLT-4

References

• 1 de Ridder S, van der Kooy F, Verpoorte R. Artemisia annua as a self-reliant treatment for malaria in developing countries.  J Ethnopharmacol. 2008;  120 302-314
• 2 Lai H, Singh N. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin.  Cancer Lett. 1995;  91 41-46
• 3 Singh N, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells.  Life Sci. 2001;  70 49-56
• 4 Moore J C, Lai H, Li J R, Ren R L, McDougall J A, Singh N P, Chou C K. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat.  Cancer Lett. 1995;  98 83-87
• 5 Disbrow G L, Baege A C, Kierpiec K A. Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo.  Cancer Res. 2005;  65 10854-10861
• 6 Lai H, Nakase I, Lacoste E, Singh N P, Sasaki T. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.  Anticancer Res. 2009;  29 3807-3810
• 7 Hou J, Wang D, Zhang R, Wang H. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.  Clin Cancer Res. 2008;  14 5519-5530
• 8 Riganti C, Doublier S, Viarisio D, Miraglia E, Pescarmona G, Ghigo D, Bhosia A. Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.  Brit J Pharmacol. 2009;  156 1054-1066
• 9 Reungpatthanaphong P, Mankhetkorn S. Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines.  Biol Pharm Bull. 2002;  25 1555-1561
• 10 Perazzo F F, Lima L M, Maistro E L, Carvalho J E, Rehder V L G, Carvalho J C T. Effect of Artemisia annua L. leaves essential oil and ethanol extract on behavioral assays.  Braz J Pharmacognosy. 2008;  18 686-689
• 11 Bilia A R, Melillo de Malgalhaes P, Bergonzi M C, Vincieri F F. Simultaneous analysis of artemisinin and flavonoids of several extracts of Artemisia annua L. obtained from a commercial sample and a selected cultivar.  Phytomedicine. 2006;  13 487-493
• 12 Ferreira J F S. Artemisia species in small ruminant production: their potential antioxidant and anthelmintic effects. Appalachian Workshop and Research Update: Improving Small Ruminant Grazing Practices Beaver, WV; 2009
• 13 Walle T. Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?.  Semin Cancer Biol. 2007;  17 354-362
• 14 Räth K, Taxis K, Walz G, Gleiter C H, Li S M, Heide L. Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (Annual Wormwood).  Am J Trop Med Hyg. 2004;  70 128-132
• 15 Ferreira J F S. Seasonal and post-harvest accumulation of artemisinin, artemisinic acid, and dihydroartemisinic acid in three accessions of Artemisia annua cultivated in West Virginia, USA.  Planta Med. 2008;  74 310-311
• 16 Prior R L, Wu X L, Schaich K. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements.  J Agric Food Chem. 2005;  53 4290-4302
• 17 Ferreira J F S, Gonzalez J M. Analysis of underivatized artemisinin and related sesquiterpene lactones by high-performance liquid chromatography with ultraviolet detection.  Phytochem Anal. 2008;  20 91-97
• 18 Wallaart T E, Pras N, Beekman A C, Quax W J. Seasonal variation of artemisinin and its biosynthetic precursors in plants of Artemisia annua of different geographical origin: proof for the existence of chemotypes.  Planta Med. 2000;  66 57-62
• 19 Squires J M, Ferreira J F S, Lindsay D S, Zajac A M. Effects of artemisinin and Artemisia and Artemisia extracts on Haemonchus contortus in gerbils (Meriones unguiculatus).  Vet Parisitol. 2011;  175 103-108
• 20 Wang J, Guo L L, Wang Y Y. Study on combination components and effectiveness of Chinese traditional herbal formulas.  Zhongguo Zhong Yao Za Zhi. 2006;  31 5-9
• 21 Lee K H. Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine.  Public Health Nutr. 2000;  3 515-522
• 22 Olsson M E, Gustavsson K, Andersson S, Nilsson Å, Duan R. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels.  J Agric Food Chem. 2004;  52 7264-7271
• 23 Ferreira J F S, Luthria D L, Sasaki T, Heyerick A. Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer.  Molecules. 2010;  15 3135-3170
• 24 Zheng G Q. Cytotoxic terpenoids and flavonoids from Artemisia annua.  Planta Med. 1994;  60 54-57
• 25 Amin A, Buratovich M. The anti-cancer charm of flavonoids: a cup-of-tea will do!.  Anticancer Drug Discov. 2007;  2 109-117
• 26 Svensson U S H, Ashton M. Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin.  Br J Clin Pharmacol. 1999;  48 528-535
• 27 Aldieri E, Atragene D, Bergandi L, Riganti C, Costamagna C, Bosia A, Ghigo D. Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-κB activation.  FEBS Lett. 2003;  552 141-144
• 28 Ulrich-Merzenich G, Panek D, Zeitler H, Wagner H, Vetter H. New perspectives for synergy research with the “omic”-technologies.  Phytomedicine. 2009;  16 495-508
• 29 Willcox M L, Bodeker G. Plant-based malaria control: research initiative on traditional antimalarial methods.  Parasitol Today. 2000;  16 220-221